Idexx Laboratories (IDXX) Gross Profit (2009 - 2026)

Idexx Laboratories' Gross Profit history runs 18 years deep, the most recent figure standing at $722.7 million for Q1 2026.

• In Q1 2026, Gross Profit rose 15.94% year-over-year to $722.7 million; the TTM figure through Mar 2026 stood at $2.8 billion (up 14.52% YoY), while the FY2025 annual figure was $2.7 billion, up 11.8% from the prior year.
• Gross Profit for Q1 2026 stood at $722.7 million, up from $658.1 million in the prior quarter.
• The five-year high for Gross Profit was $722.7 million in Q1 2026, with the low at $484.9 million in Q4 2022.
• The 5-year median for Gross Profit is $572.8 million (2023), against an average of $585.6 million.
• The sharpest annual moves came in 2022 and 2026: Gross Profit gained 5.05% in 2022, then advanced 15.94% in 2026.
• Idexx Laboratories' Gross Profit stood at $484.9 million in 2022, then rose by 8.5% to $526.2 million in 2023, then advanced by 8.46% to $570.7 million in 2024, then grew by 15.33% to $658.1 million in 2025, then rose by 9.82% to $722.7 million in 2026.
• Business Quant data shows IDXX's Gross Profit at $722.7 million in Q1 2026, $658.1 million in Q4 2025, and $683.4 million in Q3 2025.